Xeno-free serum replacement for ex vivo culture and expansion of T cells

Abstract

Background The manufacture of a majority of clinical T cell products for immunotherapy applications requires ex vivo T cell culture and expansion. Commercialization of T cell manufacturing processes requires reagents that meet regulatory guidelines and ultimately help reduce manufacturing cost of goods. A key component in many T cell culture protocols is… (More)

Topics

Cite this paper

@inproceedings{Schjetne2014XenofreeSR, title={Xeno-free serum replacement for ex vivo culture and expansion of T cells}, author={Karoline Western Schjetne and Grethe \Okern and Sandra Kuligowski and Tanja Aarvak}, year={2014} }